BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 2, 2026
Home » Authors » Khawar Khan

Articles by Khawar Khan

Pakistan working to expand vaccine production capacity

Sep. 19, 2018
By Khawar Khan
KARACHI, Pakistan – Without any domestic production capacity and facing virtually chronic shortages of vaccines on the market, Pakistan is now partnering with China to build capacity and working to create a policy environment more conducive to facilitating production.
Read More

Pakistan working to expand vaccine production capacity

Sep. 19, 2018
By Khawar Khan
KARACHI, Pakistan – Without any domestic production capacity and facing virtually chronic shortages of vaccines on the market, Pakistan is now partnering with China to build capacity and working to create a policy environment more conducive to facilitating production.
Read More

Pakistani-Canadian connects brain cells to a silicon chip

May 15, 2018
By Khawar Khan

With first WHO pre-qualification, Pakistani generics maker takes step for national industry

April 25, 2018
By Khawar Khan
KARACHI, Pakistan – Marking a significant step for Pakistan's reborn pharmaceutical industry, a domestic manufacturer received pre-qualification from the World Health Organization (WHO) for the sale of one of its products, moxifloxacin hydrochloride, for use in treating pulmonary infections as part of its tuberculosis program.
Read More

With first WHO pre-qualification, Pakistani generics maker takes step for national industry

April 23, 2018
By Khawar Khan
KARACHI, Pakistan – Marking a significant step for Pakistan's reborn pharmaceutical industry, a domestic manufacturer received pre-qualification from the World Health Organization (WHO) for the sale of one of its products, moxifloxacin hydrochloride, for use in treating pulmonary infections as part of its tuberculosis program.
Read More

From low base, Pakistan works its way up med-tech ladder

Feb. 26, 2018
By Khawar Khan

Pakistan establishes registry, implements new legislation after heart stent scandal

Sep. 13, 2017
By Khawar Khan

With new barcode system, Pakistan aims to tighten pharma industry

July 26, 2017
By Khawar Khan
KARACHI, Pakistan – The drug regulator in Pakistan is putting its foot down to enforce its planned barcoding system to address the issues of counterfeit and overpriced drugs.
Read More

In Pakistan, adopting high-end med tech a key priority

July 5, 2017
By Khawar Khan

Conundrum: Pakistan relies on smuggled drugs from India

June 28, 2017
By Khawar Khan
KARACHI, Pakistan – Despite strict laws by the Drug Regulatory Authority of Pakistan that make smuggling medicines into the country a crime punishable by a maximum sentence of 10 years' imprisonment, the problem remains rife.
Read More
Previous 1 2 3 4 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 1, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Healthy (left) vs. cancerous bone marrow

    BMS’ mezigdomide doubles PFS in multiple myeloma

    BioWorld
    Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
  • Antibodies attacking cancer cell

    ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal

    BioWorld
    Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
  • Liver over digital lens background

    EASL 2026: Emerging liver disease targets to watch

    BioWorld
    At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing